QIAGEN invests in new Barcelona facility to expand QIAstat-Dx capabilities
QIAGEN, a leading global provider of molecular diagnostics, has announced a multi-year investment in a new facility in Esplugues de Llobregat, Barcelona, to enhance its ... Read More
Tempus AI shakes up precision medicine with $600m acquisition of Ambry Genetics
Tempus AI has taken a significant step in advancing its precision medicine strategy by agreeing to acquire Ambry Genetics in a $600 million deal. This ... Read More
Recursion Pharmaceuticals and Exscientia announce merger to transform drug development
Recursion Pharmaceuticals Inc. (Nasdaq: RXRX) and Exscientia plc (Nasdaq: EXAI) have announced a landmark merger, combining their strengths to form a formidable entity in drug ... Read More
Tempus and AstraZeneca expand collaboration to enhance cancer care with AI
Tempus, a pioneer in artificial intelligence and precision medicine, has announced an expansion of its collaboration with pharmaceutical giant AstraZeneca. This enhanced partnership focuses on ... Read More
Lantern Pharma announces collaboration with Oregon Therapeutics to advance AI-driven cancer drug development
Lantern Pharma Inc. (NASDAQ: LTRN) announced a strategic collaboration with French biotech company Oregon Therapeutics to enhance the development of XCE853, a first-in-class protein disulfide ... Read More
Diamyd Medical advances Diamyd with Phase 3 trial for Type 1 Diabetes
Diamyd Medical has achieved a significant milestone in its pioneering Phase 3 trial, DIAGNODE-3, of Diamyd in Type 1 Diabetes, marking the successful enrollment of ... Read More
APx Acquisition announces merger with OmnigenicsAI and MultiplAI Health
In a landmark transaction for the biotechnology and AI industries, APx Acquisition Corp. I (NASDAQ: APXI), OmnigenicsAI Corp, and MultiplAI Health Ltd have signed a ... Read More
Microsoft and NVIDIA forge ahead with AI and cloud computing in healthcare
Microsoft Corp. is expanding its longstanding partnership with NVIDIA, setting a new benchmark in the integration of generative AI, cloud, and accelerated computing within the ... Read More
Zephyr AI announces $111m Series A to advance AI in precision medicine
Zephyr AI, Inc., a pioneering healthcare technology company committed to enhancing precision medicine through fast and explainable Artificial Intelligence (AI) solutions, has successfully closed a ... Read More
CureMatch, Spesana forge partnership to revolutionize precision medicine
In a groundbreaking development for the healthcare industry, CureMatch and Spesana have announced a strategic partnership aimed at advancing precision medicine and transforming patient care ... Read More